Infusil India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 06-07-2024
- Paid Up Capital ₹ 0.27 M
as on 06-07-2024
- Company Age 32 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.05 Cr
as on 06-07-2024
- Satisfied Charges ₹ 1.47 Cr
as on 06-07-2024
- Revenue 17.65%
(FY 2023)
- Profit 279.10%
(FY 2023)
- Ebitda 135.15%
(FY 2023)
- Net Worth 2.71%
(FY 2023)
- Total Assets 3.18%
(FY 2023)
About Infusil India
The Corporate was formerly known as Bhanu Scientific Instruments Company Pvt Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.27 M.
The company currently has active open charges totaling ₹1.05 Cr. The company has closed loans amounting to ₹1.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhanu Swamy, Swamy Ravi, and Chitgopeker Manoj serve as directors at the Company.
- CIN/LLPIN
U29224KA1992PTC012757
- Company No.
012757
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Infusil India Private Limited offer?
Infusil India Private Limited offers a wide range of products and services, including Burner Parts, Gas Burner Parts, Laboratory Glassware, Lab Adapter, Condensers, Glass Condenser, Seeding Machine, Seedling Trays, Laboratory Ware, Torchlight.
Who are the key members and board of directors at Infusil India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhanu Swamy  | Director | 14-Feb-2014 | Current |
| Swamy Ravi | Director | 16-Apr-2009 | Current |
| Chitgopeker Manoj | Director | 15-Oct-1992 | Current |
Financial Performance of Infusil India.
Infusil India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.65% increase. The company also saw a substantial improvement in profitability, with a 279.1% increase in profit. The company's net worth moved up by a moderate rise of 2.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Infusil India?
In 2023, Infusil India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Infusil Glastech Machines Private LimitedActive 33 years 26 daysBhanu Swamy, Swamy Ravi and 1 more are mutual person
- Indian Fused Quartz Private LimitedActive 45 years 11 months
Bhanu Swamy, Swamy Ravi and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Nov 2022 | ₹1.05 Cr | Open |
State Bank Of Mysore Creation Date: 09 Sep 2010 | ₹9.65 M | Satisfied |
State Bank Of Mysore Creation Date: 16 Aug 2006 | ₹5.00 M | Satisfied |
How Many Employees Work at Infusil India?
Infusil India has a workforce of 13 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Infusil India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infusil India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
